Hazardous chemicals in vaccines against swine influenza - H1N1 vaccine in MSG and Mercury

The CDC recommends that all members of the population of swine flu vaccine, especially pregnant women and children aged 6 months or more, and all those who deal with these high-risk groups receive. Consumers, however, are suspicious of the swine flu vaccine by the total absence of evidence. The potential risks from behind to understand more the H1N1 vaccine, users can read the package insert for each formulation.

The U.S. Food and DrugAdministration (FDA) provides information leaflet for all four formulations of the H1N1 vaccine. The vaccine for adults only by CSL Limited, the vaccine of Novartis Vaccines and Diagnostics Limited, which has been approved for 4 years and made the vaccine from Sanofi Pasteur Inc., which is approved for children aged between 6 months and whose above, and the intranasal vaccine for children aged 2 and up have been approved, all approved in September 2009.

All information on safety and dosage for useH1N1 vaccine package insert historical information about the vaccine against seasonal influenza, but part of the information is correct. Among the other ingredients include various formulations of the vaccine against swine flu carcinogens, mercury and MSG. While most are single-dose formulations of the H1N1 vaccine without mercury, the single-dose vials contain trace amounts of thimerosal from Novartis. Most of thimerosal, a mercury-based preservative, isremoved by a cleaning process, but remain small quantities after processing.

Before making a choice on how to receive the vaccine against swine flu, consumers should research and get all the facts about the H1N1 vaccine.

walking for health